Literature DB >> 23707296

Reactive oxygen species contribute to neuropathic pain and locomotor dysfunction via activation of CamKII in remote segments following spinal cord contusion injury in rats.

Young S Gwak1, Shayne E Hassler, Claire E Hulsebosch.   

Abstract

In this study, we examined whether blocking spinal cord injury (SCI)-induced increases in reactive oxygen species (ROS) by a ROS scavenger would attenuate below-level central neuropathic pain and promote recovery of locomotion. Rats with T10 SCI developed mechanical allodynia in both hind paws and overproduction of ROS, as assayed by Dhet intensity, in neurons in the lumbar 4/5 dorsal horn ((∗)P<0.05). To scavenge ROS, phenyl-N-tert-butylnitrone (PBN, a ROS scavenger) was administered immediately after SCI and for 7 consecutive days (early treatment) by either intrathecal (it; 1 and 3mg) or systemic (ip; 10, 50 and 100mg) injections. In addition, the high doses of it (3mg) or ip (100mg) injections were performed at 35 days (delayed treatment) after SCI. High doses of PBN (ip, 100mg, and it, 3mg) significantly attenuated mechanical allodynia in both hind paws at both early and delayed treatments, respectively ((∗)P<0.05). The abnormal hyperexcitability of wide dynamic range neurons after SCI was significantly attenuated by both early and delayed PBN treatment ((∗)P<0.05). Early PBN treatment (100mg, ip, and 3mg, it) attenuated overproduction of ROS in neurons in the lumbar 4/5 dorsal horn. In addition, it and ip t-BOOH (ROS donor) treatment dose-dependently produced mechanical allodynia in both hind paws ((∗)P<0.05). Both SCI and t-BOOH treatment groups showed significantly increased phospho-CamKII (pCamKII) expression in neurons and KN-93 (an inhibitor of pCamKII) significantly attenuated mechanical allodynia ((∗)P<0.05). In addition, high doses of PBN significantly promoted the recovery of locomotion ((∗)P<0.05). In conclusion, the present data suggest that overproduction of ROS contribute to sensory and motor abnormalities in remote segments below the lesion after thoracic SCI. Published by Elsevier B.V.

Entities:  

Keywords:  Below-level central neuropathic pain; CamKII; Hyperexcitability; Reactive oxygen species; Spinal cord injury

Mesh:

Substances:

Year:  2013        PMID: 23707296     DOI: 10.1016/j.pain.2013.05.018

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  29 in total

Review 1.  Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury.

Authors:  Alan I Faden; Junfang Wu; Bogdan A Stoica; David J Loane
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

2.  Redox Imbalance in the Peripheral Mechanism Underlying the Mirror-Image Neuropathic Pain Due to Chronic Compression of Dorsal Root Ganglion.

Authors:  H Lv; H Chen; J J Xu; Y S Jiang; Y J Shen; S Z Zhou; H Xu; Y C Xiong
Journal:  Neurochem Res       Date:  2015-10-15       Impact factor: 3.996

3.  Intrathecal Administration of Tempol Reduces Chronic Constriction Injury-Induced Neuropathic Pain in Rats by Increasing SOD Activity and Inhibiting NGF Expression.

Authors:  Baisong Zhao; Yongying Pan; Zixin Wang; Yonghong Tan; Xingrong Song
Journal:  Cell Mol Neurobiol       Date:  2015-10-03       Impact factor: 5.046

Review 4.  Nitroxidative Signaling Mechanisms in Pathological Pain.

Authors:  Peter M Grace; Andrew D Gaudet; Vasiliki Staikopoulos; Steven F Maier; Mark R Hutchinson; Daniela Salvemini; Linda R Watkins
Journal:  Trends Neurosci       Date:  2016-11-12       Impact factor: 13.837

5.  Neurorestorative targets of dietary long-chain omega-3 fatty acids in neurological injury.

Authors:  Johnny D Figueroa; Marino De Leon
Journal:  Mol Neurobiol       Date:  2014-04-17       Impact factor: 5.590

6.  Reactive oxygen species and lipid peroxidation inhibitors reduce mechanical sensitivity in a chronic neuropathic pain model of spinal cord injury in rats.

Authors:  Shayne N Hassler; Kathia M Johnson; Claire E Hulsebosch
Journal:  J Neurochem       Date:  2014-08-21       Impact factor: 5.372

7.  Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4.

Authors:  X Wang; Y Zhang; Y Peng; M R Hutchinson; K C Rice; H Yin; L R Watkins
Journal:  Br J Pharmacol       Date:  2016-02-04       Impact factor: 8.739

8.  Superoxide Dismutase-Loaded Porous Polymersomes as Highly Efficient Antioxidants for Treating Neuropathic Pain.

Authors:  Sonia Kartha; Lesan Yan; Christine L Weisshaar; Meagan E Ita; Vladimir V Shuvaev; Vladimir R Muzykantov; Andrew Tsourkas; Beth A Winkelstein; Zhiliang Cheng
Journal:  Adv Healthc Mater       Date:  2017-07-03       Impact factor: 9.933

Review 9.  Toll-like receptors and their role in persistent pain.

Authors:  Michael J Lacagnina; Linda R Watkins; Peter M Grace
Journal:  Pharmacol Ther       Date:  2017-10-04       Impact factor: 12.310

Review 10.  Allopregnanolone and Progesterone in Experimental Neuropathic Pain: Former and New Insights with a Translational Perspective.

Authors:  Susana Laura González; Laurence Meyer; María Celeste Raggio; Omar Taleb; María Florencia Coronel; Christine Patte-Mensah; Ayikoe Guy Mensah-Nyagan
Journal:  Cell Mol Neurobiol       Date:  2018-09-05       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.